Eritrea, a country on the Horn of Africa, has a developing healthcare system. While it has made strides in several areas of public health, specialized cancer care remains a significant challenge. The country lacks dedicated cancer hospitals with comprehensive treatment facilities, making cancer diagnosis and management difficult. Patients often face delays in receiving treatment, and in many cases, those who can afford it seek care abroad. Despite these challenges, a few key medical facilities in Eritrea provide some level of cancer-related services.
Notable Medical Facilities Involved in Cancer Care
1. Orotta Referral Hospital (Asmara)
Orotta Referral Hospital is one of the most prominent medical institutions in Eritrea. While it is not a dedicated cancer treatment center, it offers specialized medical services, including urology, and has been involved in pediatric oncology projects. The hospital plays an important role in diagnosing cancers and providing limited treatment options for patients within the country.
2. Sembel Reference Hospital (Asmara)
Sembel Reference Hospital is another key medical institution in Eritrea. While primarily known for its general medical services, the hospital has also been used for COVID-19 testing and treatment during the pandemic. It does not have specialized cancer treatment facilities, but it contributes to the broader healthcare infrastructure that indirectly supports cancer patients.
View this post on Instagram
3. National Health Laboratory (NHL)
Eritrea’s National Health Laboratory serves as a referral facility for histopathology and cytology services across the country. This means that while hospitals may not have dedicated oncology departments, the NHL plays a crucial role in diagnosing cancer cases. It provides laboratory services essential for identifying various types of cancer, making it a key part of Eritrea’s cancer care ecosystem.
4. Massawa Hospital (Massawa)
Massawa Hospital provides general healthcare services to residents of the coastal region. However, like other hospitals in Eritrea, it lacks dedicated cancer treatment facilities. Patients diagnosed with cancer here may be referred to Orotta Hospital for further evaluation or may be encouraged to seek treatment abroad if resources allow.
View this post on Instagram
Challenges in Cancer Care in Eritrea
Despite the presence of these medical facilities, Eritrea faces several obstacles in delivering adequate cancer care to its citizens.
1. Limited Diagnostic Capabilities
Early detection of cancer significantly increases the chances of successful treatment. However, in Eritrea, diagnostic capabilities are limited. Many hospitals do not have the necessary imaging technology, such as MRI and CT scans, to detect tumors at an early stage. The National Health Laboratory provides some histopathology and cytology services, but the overall capacity remains insufficient.
2. Lack of Specialized Cancer Treatment Centers
Unlike other African countries that have designated cancer hospitals, Eritrea does not have a dedicated oncology center. This means that most cancer patients must rely on general hospitals that lack the necessary resources for comprehensive treatment. Chemotherapy, radiotherapy, and surgical oncology services are either unavailable or extremely limited.
3. Shortage of Oncologists and Trained Healthcare Professionals
Eritrea has a severe shortage of oncologists and cancer specialists. Most physicians are general practitioners or specialists in other fields. Without trained oncologists, cancer patients often receive suboptimal care, and treatment options are limited.
4. High Cost of Cancer Treatment
Even when treatment is available, it is often expensive. The cost of chemotherapy drugs and other treatments is prohibitively high for many Eritrean families. Without government subsidies or health insurance programs covering cancer care, most people are unable to afford long-term treatment.
5. Need for International Collaboration
Due to its limited healthcare infrastructure, Eritrea relies on partnerships with international organizations to provide specialized care. Pediatric oncology projects and training programs for local healthcare workers have been supported by foreign institutions, but more collaboration is needed to improve cancer care accessibility.
Possible Solutions and Future Prospects
Addressing these challenges requires a multi-faceted approach involving both local and international efforts. Here are some possible strategies to improve cancer care in Eritrea:
1. Establishing a Dedicated Cancer Treatment Center
A key step in improving cancer care in Eritrea is the establishment of a dedicated oncology hospital. Such a facility would provide specialized treatment, including chemotherapy and radiotherapy, and serve as a training hub for local healthcare workers.
2. Strengthening Diagnostic Services
Investing in better diagnostic tools, such as CT scans, MRIs, and biopsy analysis, can help detect cancer at earlier stages. Expanding the capabilities of the National Health Laboratory would also be an effective way to enhance early cancer detection in the country.
3. Training More Oncologists and Healthcare Professionals
Building a workforce of trained oncologists, nurses, and support staff is crucial. The Eritrean government can partner with international medical institutions to provide training programs for local healthcare workers. Additionally, encouraging Eritrean medical students to specialize in oncology can help bridge the gap.
4. Improving Access to Affordable Treatment
Lowering the cost of cancer treatment is essential. The government can explore bulk purchasing agreements for chemotherapy drugs, establish subsidy programs, and encourage non-profit organizations to assist in providing free or low-cost treatments to low-income patients.
5. Expanding Public Awareness and Preventive Measures
Cancer prevention is just as important as treatment. Awareness campaigns about risk factors such as smoking, poor diet, and lack of physical activity can help reduce the incidence of preventable cancers. Encouraging routine screenings for breast and cervical cancer can also lead to earlier diagnoses and better outcomes.
Conclusion
Eritrea’s healthcare system faces significant challenges in providing comprehensive cancer care. The lack of specialized hospitals, limited diagnostic capabilities, and shortage of trained oncologists all contribute to the difficulty of managing cancer cases effectively. However, there are signs of progress. With targeted investments in diagnostic services, oncology training, and international collaboration, Eritrea can take important steps toward improving cancer treatment for its population.
While many Eritreans currently have to seek treatment abroad, building a strong local cancer care system can change that. It will take time, effort, and financial investment, but the benefits will be life-changing for thousands of patients in need. As awareness grows and global partnerships continue to develop, the future of cancer care in Eritrea holds promise.
